|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 14, 2017 ) Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat damaged or diseased human cells, tissues, or organs. It focuses on repairing, replacing, or regenerating damaged cells, and thus offers a paradigm shift in healthcare treatment. The three main technologies used in regenerative medicine are small molecules and biologics, gene therapy, and cell therapy. Small molecules and biologics help in the regeneration of diseased cells and tissues, whereas cell therapy helps in treating the functioning of existing cells.
Publisher's analysts forecast the regenerative medicine market in Japan to grow at a CAGR of 35.3% during the period 2016-2020.
For more information http://www.reportsweb.com/regenerative-medicine-market-in-japan-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the regenerative medicine market in Japan for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of regenerative medicine products to end-users like hospitals, ambulatory surgical centers (ASCs), and clinical research laboratories.
The market is divided into the following segments based on product:
-Tissue Scaffold
-Cell Therapy
Publisher's report, Regenerative Medicine Market in Japan 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-CellSeed
-JCR Pharmaceuticals
-Japan Tissue Engineering
-Terumo
-Astellas
-Caladrius Biosciences
-Healios
-Fujifilm
-Rohto Pharmaceuticals
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001420966/sample
Other prominent vendors
-FUJISOFT Tissue Engineering
-MediBIC
-MEDI NET
-Nikon
-TAKARA
-CMIC
-EPS
-Cyfuse Biomedical
-Irvine Scientific
-Kaken
-Regience
-Sumitomo Dainippon
-Takeda
-Alfresa
-MEDIPAL Holdings
-TOHO
Market driver
-Growing partnerships of MNCs with local vendors in Japan
-For a full, detailed list, view our report
Market challenge
-High cost and failure rate in clinical trials coupled with inadequate clinical evidence
-For a full, detailed list, view our report
Market trend
-Strong pipeline portfolio of regenerative medicines
-For a full, detailed list, view our report
Companies Mentioned:
3M
BioEnable
NEC
Safran
ZKTeco
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001420966/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
